Capital Advisors Inc’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-203,775
| Closed | -$4.19M | – | 312 |
|
|
2024
Q3 | $4.19M | Sell |
203,775
-107,270
| -34% | -$2.2M | 0.08% | 102 |
|
|
2024
Q2 | $6.96M | Buy |
311,045
+10,392
| +3% | +$233K | 0.14% | 97 |
|
|
2024
Q1 | $8.27M | Buy |
300,653
+15,915
| +6% | +$438K | 0.18% | 96 |
|
|
2023
Q4 | $8.68M | Buy |
284,738
+73,379
| +35% | +$2.24M | 0.19% | 95 |
|
|
2023
Q3 | $6.68M | Buy |
211,359
+14,539
| +7% | +$460K | 0.18% | 87 |
|
|
2023
Q2 | $8.03M | Buy |
196,820
+8,440
| +4% | +$344K | 0.2% | 90 |
|
|
2023
Q1 | $7.02M | Buy |
188,380
+14,724
| +8% | +$549K | 0.19% | 90 |
|
|
2022
Q4 | $6.06M | Buy |
173,656
+1,802
| +1% | +$62.9K | 0.17% | 90 |
|
|
2022
Q3 | $9M | Buy |
171,854
+4,528
| +3% | +$237K | 0.28% | 83 |
|
|
2022
Q2 | $8.66M | Buy |
167,326
+82,405
| +97% | +$4.27M | 0.26% | 89 |
|
|
2022
Q1 | $6.17M | Buy |
84,921
+5,378
| +7% | +$391K | 0.17% | 89 |
|
|
2021
Q4 | $9.41M | Buy |
79,543
+35,298
| +80% | +$4.17M | 0.25% | 90 |
|
|
2021
Q3 | $5.94M | Buy |
44,245
+42,145
| +2,007% | +$5.65M | 0.18% | 97 |
|
|
2021
Q2 | $340K | Buy |
+2,100
| New | +$340K | 0.01% | 188 |
|
|
2018
Q4 | – | Sell |
-110,239
| Closed | -$3.16M | – | 191 |
|
|
2018
Q3 | $3.16M | Buy |
110,239
+2,327
| +2% | +$66.6K | 0.19% | 96 |
|
|
2018
Q2 | $2.95M | Sell |
107,912
-513
| -0.5% | -$14K | 0.18% | 98 |
|
|
2018
Q1 | $2.29M | Buy |
108,425
+7,195
| +7% | +$152K | 0.14% | 105 |
|
|
2017
Q4 | $1.95M | Buy |
+101,230
| New | +$1.95M | 0.11% | 108 |
|